Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Leases (2019 - 2025)

Veracyte (VCYT) has disclosed Current Leases for 7 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Current Leases fell 45.99% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 45.99% year-over-year, with the annual reading at $4.1 million for FY2025, 45.99% down from the prior year.
  • Current Leases hit $4.1 million in Q4 2025 for Veracyte, down from $4.3 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $7.5 million in Q4 2024 to a low of $2.9 million in Q1 2021.
  • Historically, Current Leases has averaged $4.9 million across 5 years, with a median of $4.2 million in 2023.
  • Biggest five-year swings in Current Leases: surged 128.45% in 2021 and later crashed 45.99% in 2025.
  • Year by year, Current Leases stood at $3.6 million in 2021, then grew by 12.12% to $4.1 million in 2022, then increased by 25.43% to $5.1 million in 2023, then skyrocketed by 46.91% to $7.5 million in 2024, then plummeted by 45.99% to $4.1 million in 2025.
  • Business Quant data shows Current Leases for VCYT at $4.1 million in Q4 2025, $4.3 million in Q3 2025, and $6.4 million in Q2 2025.